|
ES2211904T3
(es)
*
|
1995-05-26 |
2004-07-16 |
Pfizer Inc. |
Combinaciones para el tratamiento del parkinsonismo que contienen antagonistas selectivos de nmda.
|
|
DE69834500T2
(de)
*
|
1997-09-05 |
2007-05-03 |
Kyowa Hakko Kogyo Co., Ltd. |
Xanthinderivative zur behandlung von hirnischämie
|
|
IL146334A0
(en)
|
1999-05-10 |
2002-07-25 |
Univ Princeton |
Compositions and methods for inproving learning and memory
|
|
EP1235572A2
(en)
|
1999-10-29 |
2002-09-04 |
MERCK SHARP & DOHME LTD. |
Method to treat pain utilizing benzimidazole nmda/nr2b antagonists
|
|
US6369076B1
(en)
|
1999-10-29 |
2002-04-09 |
Merck & Co. Inc. |
5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline NMDA/NR2B antagonists
|
|
US6432976B1
(en)
|
1999-10-29 |
2002-08-13 |
Merck & Co., Inc. |
8-aza-bicyclo[3.2.1]octane NMDA/NR2B antagonists
|
|
US6476041B1
(en)
|
1999-10-29 |
2002-11-05 |
Merck & Co., Inc. |
1,4 substituted piperidinyl NMDA/NR2B antagonists
|
|
US6316474B1
(en)
|
1999-10-29 |
2001-11-13 |
Merck & Co., Inc. |
2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists
|
|
US6291499B1
(en)
|
1999-10-29 |
2001-09-18 |
Merck & Co., Inc. |
2-cyclohexyl benzimidazole NMDA/NR2B antagonists
|
|
US6489477B1
(en)
|
1999-10-29 |
2002-12-03 |
Merck & Co., Inc. |
2-aza-bicyclo[2.2.2]octane NMDA/NR2B antigonists
|
|
GB0015488D0
(en)
|
2000-06-23 |
2000-08-16 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
JP2004501901A
(ja)
|
2000-06-26 |
2004-01-22 |
メルク エンド カムパニー インコーポレーテッド |
イミノピリミジン系ｎｍｄａｎｒ２ｂ受容体拮抗薬
|
|
AU2001277273A1
(en)
|
2000-07-27 |
2002-02-13 |
Washington University |
Methods and agents for treating persistent pain
|
|
AU2001280996A1
(en)
|
2000-08-04 |
2002-02-18 |
Cis Biotech, Inc. |
Rapid multiple panel of biomarkers in laboratory blood tests for tia/stroke
|
|
HU227197B1
(en)
|
2000-10-24 |
2010-10-28 |
Richter Gedeon Nyrt |
Nmda receptor antagonist carboxylic acid amide derivatives and pharmaceutical compositions containing them
|
|
WO2002068409A1
(en)
|
2001-02-23 |
2002-09-06 |
Merck & Co., Inc. |
N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
|
|
US7259157B2
(en)
|
2001-04-03 |
2007-08-21 |
Merck & Co., Inc. |
N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists
|
|
US20040204341A1
(en)
|
2001-06-12 |
2004-10-14 |
Christopher Allen |
Nr2b receptor antagonists for the treatment or prevention of migraines
|
|
ATE408611T1
(de)
|
2001-07-24 |
2008-10-15 |
Richter Gedeon Nyrt |
Piperidine als nmda-rezeptorantagonisten
|
|
WO2003084931A1
(en)
|
2002-04-02 |
2003-10-16 |
Merck & Co., Inc. |
5h-benzo[4,5]cyclohepta[1,2-b]pyridine nmda/nr2b antagonists
|
|
US6713490B2
(en)
|
2002-04-26 |
2004-03-30 |
Pfizer, Inc. |
3,4-dihydroquinolin-2(1H)-one compounds as NR2B receptor antagonists
|
|
AU2003291074A1
(en)
|
2002-11-22 |
2004-06-18 |
Merck & Co., Inc. |
2-[(4-benzyl)-1-piperidinyl)methyl]benzimidazole-5-ol derivatives as NR2B receptor antagonists
|
|
MXPA05006487A
(es)
|
2002-12-17 |
2005-08-26 |
Pfizer |
Compuestos cicloalquilenamida como antagonistas de receptor nr2b.
|
|
US20060106040A1
(en)
|
2002-12-19 |
2006-05-18 |
Michael Grzelak |
Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders
|
|
US20060128694A1
(en)
|
2002-12-19 |
2006-06-15 |
Michael Grzelak |
Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders
|
|
BRPI0409241A
(pt)
|
2003-04-10 |
2006-03-28 |
Pfizer |
compostos bicìclicos como antagonistas do receptor de nr2b, composições farmacêuticas compreendendo os mesmos e seu uso
|
|
ATE403651T1
(de)
|
2003-06-04 |
2008-08-15 |
Merck & Co Inc |
3-fluoro-piperidine als nmda/nr2b antagonisten
|
|
EP1656379B1
(en)
|
2003-08-15 |
2007-01-10 |
Merck & Co., Inc. |
4-cycloalkylaminopyrazolo pyrimidine nmda/nr2b antagonists
|
|
WO2005019222A1
(en)
|
2003-08-15 |
2005-03-03 |
Merck & Co., Inc. |
4-cycloalkylaminopyrazolo pyrimidine nmda/nr2b antagonists
|
|
WO2005030720A1
(ja)
|
2003-09-25 |
2005-04-07 |
Shionogi & Co., Ltd. |
Ｎｍｄａ受容体拮抗作用を有するピペリジン誘導体
|
|
BRPI0415109A
(pt)
|
2003-10-08 |
2006-11-28 |
Pfizer |
compostos de 1-[2-(4-hidroxifenil)-2-hidroxietil]-piperidin-4-ol como antagonistas de receptor de nmda
|
|
MXPA06003748A
(es)
|
2003-10-08 |
2006-06-14 |
Pfizer |
Compuestos de lactama condensada.
|
|
EP1716100A2
(en)
|
2004-02-11 |
2006-11-02 |
Pfizer, Inc. |
Therapeutic amide derivatives
|
|
WO2005102390A2
(en)
|
2004-04-22 |
2005-11-03 |
Pfizer Japan, Inc. |
Combinations comprising alpha-2-delta ligands and nmda receptor antagonists
|
|
CN1956983B
(zh)
*
|
2004-05-24 |
2010-05-26 |
弗·哈夫曼-拉罗切有限公司 |
4-羟基-4-甲基-哌啶-1-甲酸(4-甲氧基-7-吗啉-4-基-苯并噻唑-2-基)-酰胺
|
|
HU226977B1
(en)
|
2004-07-29 |
2010-04-28 |
Richter Gedeon Nyrt |
Kynurenic acid amide derivatives, pharmaceutical compositions containing them and process for producing them
|
|
HUP0401522A2
(en)
|
2004-07-29 |
2006-04-28 |
Richter Gedeon Vegyeszet |
New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
|
|
WO2006017409A2
(en)
|
2004-08-03 |
2006-02-16 |
Merck & Co., Inc. |
1,3-disubstituted heteroaryl nmda/nr2b antagonists
|
|
US20090041751A1
(en)
|
2005-02-01 |
2009-02-12 |
University Of Medicine And Dentistry Of New Jersey |
Sepsis Prevention Through Adenosine Receptor Modulation
|
|
WO2006113471A2
(en)
|
2005-04-19 |
2006-10-26 |
Merck & Co., Inc. |
N-alkyl-azacycloalkyl nmda/nr2b antagonists
|
|
EP1885365A4
(en)
|
2005-05-13 |
2012-07-11 |
The Feinstein Inst Medical Res |
TREATMENT OF SEPSIS AND INFLAMMATION WITH ADRENEER ALPHA2A ANTAGONISTS
|
|
JPWO2006129626A1
(ja)
|
2005-05-30 |
2009-01-08 |
協和醗酵工業株式会社 |
［１，２，４］トリアゾロ［１，５−ｃ］ピリミジン誘導体の製造法
|
|
US20100280023A1
(en)
|
2005-06-23 |
2010-11-04 |
Kyowa Hakko Kogyo Co., Ltd. |
Thiazole derivatives
|
|
JPWO2006137465A1
(ja)
|
2005-06-24 |
2009-01-22 |
塩野義製薬株式会社 |
含窒素複素環誘導体
|
|
US20100048653A1
(en)
|
2005-07-14 |
2010-02-25 |
The University Of British Columbia |
Neuroprotective modulation of nmda receptor subtype activities
|
|
WO2007063286A2
(en)
|
2005-11-29 |
2007-06-07 |
Hammersmith Imanet Limited |
Amidine derivatives for in vivo imaging
|
|
JPWO2007063839A1
(ja)
|
2005-11-30 |
2009-05-07 |
塩野義製薬株式会社 |
シクロヘキサン誘導体
|
|
WO2007099828A1
(ja)
|
2006-02-23 |
2007-09-07 |
Shionogi & Co., Ltd. |
環式基で置換された含窒素複素環誘導体
|
|
ATE457988T1
(de)
*
|
2006-06-26 |
2010-03-15 |
Schering Corp |
A2a-adenosin-rezeptor-antagonisten
|
|
CN101646434A
(zh)
|
2006-11-09 |
2010-02-10 |
公共健康研究中心 |
腺苷拮抗剂的用途
|
|
US8304198B2
(en)
|
2007-06-19 |
2012-11-06 |
Rajiv Gandhi Centre For Biotechnology |
Assay for detection of transient intracellular CA2+
|
|
US20110251212A1
(en)
|
2007-08-21 |
2011-10-13 |
Shionogi & Co., Ltd. |
Piperazine derivatives
|
|
US20090181934A1
(en)
|
2007-10-17 |
2009-07-16 |
Novartis Ag |
Organic Compounds
|
|
JP2011500819A
(ja)
|
2007-10-24 |
2011-01-06 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
アリルインデノピリミジン及びアデノシンＡ２ａ受容体拮抗物質としてのそれらの使用
|
|
WO2009054544A1
(en)
*
|
2007-10-26 |
2009-04-30 |
Eisai R & D Management Co., Ltd. |
Ampa receptor antagonists for parkinson's disease and movement disorders
|
|
EP2215073A4
(en)
|
2007-10-31 |
2011-04-06 |
Merck Sharp & Dohme |
SLEEP MODULATION WITH NR2B RECEPTOR ANTAGONISTS
|
|
MX2010009649A
(es)
|
2008-03-27 |
2010-12-17 |
Evotecv Neurosciences Gmbh |
Metodos para tratar trastornos utilizando un antagonista selectivo del subtipo nr2b de nmda.
|
|
US8684624B2
(en)
|
2008-07-01 |
2014-04-01 |
Saint-Gobain Performance Plastics Rencol Limited |
Tolerance ring
|
|
WO2010003712A1
(de)
|
2008-07-09 |
2010-01-14 |
Siemens Aktiengesellschaft |
Verfahren, kommunikationsverbund und software zum auffinden von gesuchten objekten
|
|
EP2144462A1
(en)
|
2008-07-09 |
2010-01-13 |
Nokia Siemens Networks OY |
Reduced resource allocation parameter signalling
|
|
AU2009282822A1
(en)
*
|
2008-08-21 |
2010-02-25 |
Richter Gedeon Nyrt. |
Methods for treating CNS disorders
|
|
EP2344145A1
(en)
|
2008-09-29 |
2011-07-20 |
Gilead Sciences, Inc. |
Combinations of a rate control agent and an a-2-alpha receptor antagonist for use in multidetector computed tomography methods
|
|
US8536306B2
(en)
|
2008-10-01 |
2013-09-17 |
The Scripps Research Institute |
Human A2A adenosine receptor crystals and uses thereof
|
|
US8282042B2
(en)
|
2009-06-22 |
2012-10-09 |
The Boeing Company |
Skin panel joint for improved airflow
|
|
US8301311B2
(en)
|
2009-07-06 |
2012-10-30 |
Siemens Aktiengesellschaft |
Frequency-responsive wind turbine output control
|
|
US20110007639A1
(en)
|
2009-07-10 |
2011-01-13 |
Qualcomm Incorporated |
Methods and apparatus for detecting identifiers
|
|
US20110105540A1
(en)
|
2009-10-29 |
2011-05-05 |
Jackson Paul F |
2-AMINO-9-[4-(4-METHOXY-PHENOXY)-PIPERIDIN-1-YL]-4-PHENYL-INDENO[1,2-D]PYRIMIDIN-5-ONE AND ITS USE AS A HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONIST
|
|
DE102010026274A1
(de)
|
2010-07-06 |
2012-01-12 |
Voith Patent Gmbh |
Bremsanlage und Verfahren zum Einstellen eines Bremsmomentes einer solchen
|
|
JP5843869B2
(ja)
*
|
2010-09-24 |
2016-01-13 |
アドヴィナス・セラピューティックス・リミテッド |
アデノシン受容体拮抗薬としての縮合三環化合物
|